Aethlon Medical Investor Relations Material

Aethlon Medical, Inc. is an American MedTech company that focuses on developing products to diagnose and treat organ threatening diseases. Aethlon is focused on the capturing and therapeutic depletion of reproductively-active viruses, including Ebola and Hepatitis C, via a device approached called Hemopurifier. The company's first clinical program seeks to address the need for new interventions that can help reduce viral load in Ebola infected individuals.